Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ 0
Profit
Caution€ -8.8 million
▼ 458% vs 2024
Debts
Low€ 388,295
▲ 38% vs 2024
Heran HealthTech Fund I from Antwerpen, company number BE0747662241, closed financial year 2025 with a result of € -8.8 million after tax. For that financial year Heran HealthTech Fund I recorded a gross margin of € 0 and equity of € 27.2 million. Compared with financial year 2024, the result moved from € -1.6 million to € -8.8 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 6, 2025.
What happened at Heran HealthTech Fund I?
What happened at Heran HealthTech Fund I in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 8.8 million. Source: NBB ↗
- New establishment in Antwerpen. KBO
- Heran Partners BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 9.8 million profit in 2022 to € 8.8 million loss in 2025.
Best year ever: 2023, with € 16 million profit.
Paid out € 17.4 million in dividends to the owners in total.
Pays suppliers within 92 days on average.
A new publication or filing at Heran HealthTech Fund I? We notify you, reason included.
Follow Heran HealthTech Fund INeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Heran HealthTech Fund I is Heran Partners BV. It owns 36.8% of ImmuneSpec, 28.2% of FOx Biosystems (in faillissement), 27.8% of ASPECT ANALYTICS, 26.7% of AMARON, 19.6% of ONTOFORCE and 16.9% of Thirona itself.
Directors
According to the 2025 annual accounts
Manager · represented by Katleen VANDERSMISSEN
Also active at: Lynxcare Clinical Informatics, FOx Biosystems, ASPECT ANALYTICS +5 more
since 2020
Establishments
Establishment units
Physical locations of this company
Amerikalei 64 box 5
2000 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0747.662.241
- VAT number
- BE 0747.662.241
- Registered office
- Amerikalei 64 bus 5, 2000 Antwerpen
- Names & denominations
- Heran HealthTech Fund I
- Enterprise type
- Rechtspersoon
- Legal form
- Limited partnership
- Legal situation
- Normale toestand
- Start date
- 27 May 2020
- Peppol
- Active · Active since 7 Oct 2025
- Activities · NACE
Activiteiten van holdings
Holdings